CORONARY ANGIOGRAPHIC CHARACTERISTICS IN JAPANESE PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引:19
|
作者
GENDA, A [1 ]
NAKAYAMA, A [1 ]
SHIMIZU, M [1 ]
NUNODA, S [1 ]
SUGIHARA, N [1 ]
SUEMATZU, T [1 ]
KITA, Y [1 ]
YOSHIMURA, A [1 ]
KOIZUMI, J [1 ]
MABUCHI, H [1 ]
TAKEDA, R [1 ]
机构
[1] KANAZAWA UNIV,SCH MED,CTR HLTH CARE,KANAZAWA,ISHIKAWA 920,JAPAN
关键词
D O I
10.1016/0021-9150(87)90176-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:29 / 36
页数:8
相关论文
共 50 条
  • [31] Impact of coronary artery calcium on the prognosis of heterozygous familial hypercholesterolemia
    Tada, H.
    Nomura, A.
    Usui, S.
    Sakata, K.
    Takamura, M.
    Kawashiri, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [32] EFFECT OF BONE METABOLISM ON CORONARY CALCIFICATION IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Cohen, Samuel
    Lesnik, Philippe
    Guerin, Maryse
    Pirbay, Taha
    Carreau, Valerie
    Zarai, Mohamed
    Charpentier, Etienne
    Kachenoura, Nadjia
    Le Goff, Wilfried
    Helft, Gerard
    Redhueil, Alban
    Bruckert, Eric
    Gallo, Antonio
    ATHEROSCLEROSIS, 2024, 395
  • [33] Relationship of hypertension with coronary artery disease in patients with heterozygous familial hypercholesterolemia: The role of gender
    Masoura, C.
    Pitsavos, C.
    Skoumas, J.
    Vlachopoulos, C.
    Papadimitriou, L.
    Aznaouridis, K.
    Chrysohoou, C.
    Giotsas, N.
    Stefanadis, C.
    JOURNAL OF HYPERTENSION, 2007, 25 : S209 - S210
  • [34] Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and coronary heart disease in patients with heterozygous familial hypercholesterolemia
    Perani, G
    Tinelli, C
    Scullino, T
    Sartori, M
    Minoretti, P
    Geroldi, D
    Emanuele, E
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 143 - 143
  • [35] Defining Patients at Extremely High Risk for Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia
    Sugisawa, Takako
    Okamura, Tomonori
    Makino, Hisashi
    Watanabe, Makoto
    Kishimoto, Ichiro
    Miyamoto, Yoshihiro
    Iwamoto, Noriyuki
    Yamamoto, Akira
    Yokoyama, Shinji
    Harada-Shiba, Mariko
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (04) : 369 - 375
  • [36] Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Heterozygous Familial Hypercholesterolemia and Null Allele Low-Density Lipoprotein Receptor Mutations
    Vilades Medel, David
    Leta Petracca, Ruben
    Carreras Costa, Francesc
    Cardona Olle, Montserrat
    Barros Membrilla, Antonio
    Hidalgo Perez, Jose Alberto
    Pujadas Olano, Sandra
    Alomar Serrallach, Xavier
    Franco Peral, Miguel
    Pons-Llado, Guillem
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (07): : 955 - 961
  • [37] Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients
    Hori, Mika
    Ohta, Naotaka
    Takahashi, Atsushi
    Masuda, Hiroaki
    Isoda, Rieko
    Yamamoto, Suguru
    Son, Cheol
    Ogura, Masatsune
    Hosoda, Kiminori
    Miyamoto, Yoshihiro
    Harada-Shiba, Mariko
    ATHEROSCLEROSIS, 2019, 289 : 101 - 108
  • [38] When should patients with heterozygous familial hypercholesterolemia be treated?
    Rifkind, BM
    Schucker, B
    Gordon, DJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (02): : 180 - 181
  • [39] Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
    Nicholls, Stephen
    Nelson, Adam
    Ditmarsch, Marc
    Kastelein, John
    Ballantyne, Christie
    Ray, Kausik
    Navar, Ann Marie
    Nissen, Steven
    Goldberg, Anne
    Brunham, Liam
    Wuerdeman, Erin
    Neild, Annie
    Kling, Douglas
    Hsieh, Andrew
    Ference, Brian
    Laufs, Ulrich
    Banach, Maciej
    Mehran, Roxana
    Catapano, Alberico
    Davidson, Michael
    CIRCULATION, 2024, 150 (25) : E729 - E730
  • [40] HYPOCHOLESTEROLEMIC EFFECTS OF MEVINOLIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    ILLINGWORTH, DR
    SEXTON, GJ
    JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06): : 1972 - 1978